key: cord-0766998-gg6ni2uj
authors: Wiwanitkit, V.
title: QTc interval prolongation, COVID-19 and chloroquine
date: 2020-10-08
journal: Neth Heart J
DOI: 10.1007/s12471-020-01506-x
sha: 77ef725942b13e63bd14bd761edd76ca55a13697
doc_id: 766998
cord_uid: gg6ni2uj

nan

any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine

Prophylactic RCA. (hydroxy) chloroquine in COVID-19: potential relevance for cardiac arrhythmia risk

COVID-19 pandemic: cardiovascular complications and future implications

QTc interval prolongation, COVID-19 and chloroquine